Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 17 for:    neuroblastoma, IL2
Previous Study | Return to List | Next Study

Treatment of Relapsed or Refractory Neuroblastoma With Expanded Haploidentical NK Cells and Hu14.18-IL2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03209869
Recruitment Status : Suspended (resources limited due to COVID-19)
First Posted : July 6, 2017
Last Update Posted : September 9, 2020
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Solving Kids' Cancer
Midwest Athletes Against Childhood Cancer, Inc. (MACC Fund)
Wade's Army
The Catherine Elizabeth Blair Memorial Foundation / GWCF
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : September 1, 2021
Estimated Study Completion Date : September 1, 2021